Search results

Measurements of the naturally-occurring radioactive gas radon can be used to accurately categorise the degree of atmospheric mixing.

ANSTO continues a longstanding, mutually-beneficial research relationship with the University of Wollongong following the signing of a strategic agreement this week.

This COVIDSafe Plan describes the actions that ANSTO will take to keep our staff, contractors and visitors and platform users and collaborators safe and minimise the risk of the spread of COVID-19 infection.

ANSTO scientists are participating investigators in three new ARC Industrial Transformation Training Centres, recently announced by the Government.

The installation of a cold neutron source (CNS), a component that reduces the energy and speed of the neutrons from a research reactor for use in scientific instruments, was successfully completed in September 2024.

ANSTO providing support to emergency services, closed to non-essential staff.

A special inaugural event held by ANSTO at its Australian Synchrotron for more than 30 funding organisations has showcased the first of the $100 million BRIGHT Program’s brand new, state-of-the-art beamlines.

ANSTO is a major supplier of Australia’s radioactive isotopes used in nuclear medicine, delivering around 10,000 patient doses each week.  Health-based research and development in Australia and overseas also benefit greatly from ANSTO’s unique capabilities and expertise in the detection, diagnosis and treatment of disease using nuclear and accelerator infrastructure.​

Research has demonstrated that internally generated neutrons could be used to effectively target micro-infiltrates and cancer cells outside of the defined treatment regions.

Research to improve knowledge of natural variability in rainfall and recharge by monitoring hydrological processes in key regions and reconstruct water recharge history.

Clarity Pharmaceuticals is building on comprehensive work on chelators carried out at ANSTO.

Australian clean energy technology company, entX Limited is taking advantage of ANSTO’s unique capacity to generate tailored radioisotope products in the OPAL multi-purpose nuclear reactor to advance a series of innovative projects.

Year 11 STEM student and aspiring physicist was given the opportunity of a lifetime to tour ANSTO’s Lucas Heights campus and meet some of Australia’s top researchers.